VIROMETIX AG has a total of 17 patent applications. Its first patent ever was published in 2014. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Canada. Its main competitors in its focus markets biotechnology and pharmaceuticals are OURO FINO SAÚDE ANIMAL LTDA, STEMIMMUNE INCORPORATED and GENITRIX LLC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 3 | |
#2 | WIPO (World Intellectual Property Organization) | 3 | |
#3 | Canada | 2 | |
#4 | China | 2 | |
#5 | EPO (European Patent Office) | 2 | |
#6 | Republic of Korea | 2 | |
#7 | Hong Kong | 1 | |
#8 | Japan | 1 | |
#9 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Microorganisms | |
#3 | Therapeutic chemical compounds | |
#4 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Ghasparian Arin | 16 |
#2 | Marrero Nodarse Aniebrys | 15 |
#3 | Zuniga Armando | 15 |
#4 | Geib Nina | 9 |
#5 | Robinson John Anthony | 9 |
#6 | Jud Maja | 9 |
#7 | Pluschke Gerd | 9 |
#8 | Tamborini Marco | 8 |
#9 | Robinson John A | 7 |
#10 | Rassek Oliver | 6 |
Publication | Filing date | Title |
---|---|---|
WO2020127728A1 | Lipopeptide building blocks and synthetic virus-like particles | |
KR20200018483A | Cyclic Peptides for Defense Against Respiratory Syndrome Virus | |
KR20160088323A | Proline-rich peptides protective against S. pneumoniae |